Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FNA - Paragon 28 Inc


Close
8.32
0.050   0.601%

Share volume: 284,810
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$8.27
0.05
0.61%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
9%
Profitability 0%
Dept financing 19%
Liquidity 34%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
-2.80%
1 Month
-7.86%
3 Months
6.94%
6 Months
-31.52%
1 Year
-41.16%
2 Year
-51.52%
Key data
Stock price
$8.32
P/E Ratio 
-12.08
DAY RANGE
$8.16 - $8.51
EPS 
-$0.70
52 WEEK RANGE
$5.55 - $14.79
52 WEEK CHANGE
-$0.44
MARKET CAP 
695.072 M
YIELD 
N/A
SHARES OUTSTANDING 
83.542 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
1.40
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$305,570
AVERAGE 30 VOLUME 
$644,788
Company detail
CEO: Albert DaCosta
Region: US
Website: paragon28.com
Employees: 625
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

paragon 28 was established in 2010 as an orthopedic foot and ankle company. the name “paragon 28” was chosen to show that we are exclusively a foot and ankle company, with the “28” representing the number of bones in the foot. we will remain true to that vision. paragon 28 was started as a small, family-based company and we have kept those core ideals as we have grown. our mission is to strategically build a company around the core principles that drive innovation and quality. relentlessly working to advance the science behind foot and ankle surgery, paragon 28 is passionate about and committed to: - creation and innovation: blending different surgical philosophies from various global thought leaders to develop bio-mechanically and clinically relevant surgical solutions. - a focus on service: a customer service based, dedicated, and highly trained distribution network to the foot and ankle market. - efficient practices: meeting the needs of increasing pricing pressures and reimbursemen

Recent news